Publication:
Cell death mechanisms in stroke and novel molecular and cellular treatment options

dc.contributor.kuauthorŞekerdağ, Emine
dc.contributor.kuauthorSolaroğlu, İhsan
dc.contributor.kuauthorÖzdemir, Yasemin Gürsoy
dc.contributor.kuprofilePhD Student
dc.contributor.kuprofileFaculty Member
dc.contributor.kuprofileFaculty Member
dc.contributor.researchcenterKoç University Research Center for Translational Medicine (KUTTAM) / Koç Üniversitesi Translasyonel Tıp Araştırma Merkezi (KUTTAM)
dc.contributor.schoolcollegeinstituteGraduate School of Health Sciences
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.yokidN/A
dc.contributor.yokid102059
dc.contributor.yokid170592
dc.date.accessioned2024-11-09T23:49:38Z
dc.date.issued2018
dc.description.abstractAs a result of ischemia or hemorrhage, blood supply to neurons is disrupted which subsequently promotes a cascade of pathophysiological responses resulting in cell loss. Many mechanisms are involved solely or in combination in this disorder including excitotoxicity, mitochondrial death pathways, and the release of free radicals, protein misfolding, apoptosis, necrosis, autophagy and inflammation. Besides neuronal cell loss, damage to and loss of astrocytes as well as injury to white matter contributes also to cerebral injury. The core problem in stroke is the loss of neuronal cells which makes recovery difficult or even not possible in the late states. Acute treatment options that can be applied for stroke are mainly targeting re-establishment of blood flow and hence, their use is limited due to the effective time window of thrombolytic agents. However, if the acute time window is exceeded, neuronal loss starts due to the activation of cell death pathways. This review will explore the most updated cellular death mechanisms leading to neuronal loss in stroke. Ischemic and hemorrhagic stroke as well as subarachnoid hemorrhage will be debated in the light of cell death mechanisms and possible novel molecular and cellular treatment options will be discussed.
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue9
dc.description.openaccessYES
dc.description.volume16
dc.identifier.doi10.2174/1570159X16666180302115544
dc.identifier.eissn1875-6190
dc.identifier.issn1570-159X
dc.identifier.scopus2-s2.0-85052760195
dc.identifier.urihttp://dx.doi.org/10.2174/1570159X16666180302115544
dc.identifier.urihttps://hdl.handle.net/20.500.14288/14403
dc.identifier.wos446492500016
dc.keywordsIschemic stroke
dc.keywordsHemorrhagic stroke
dc.keywordsApoptosis
dc.keywordsNecrosis
dc.keywordsAutophagy
dc.keywordsPyroptosis
dc.keywordsNeuroprotective therapies
dc.keywordsIschemıc brain-injury
dc.keywordsEndoplasmic-reticulum stress
dc.keywordsFocal cerebral-ischemia
dc.keywordsNeuronal death
dc.keywordsIntracerebral hemorrhage
dc.keywordsOxidatıve stress
dc.keywordsProtects neurons
dc.keywordsChondroitınase Abc
dc.keywordsNlrp3 inflammasome
dc.keywordsCysteine proteases
dc.languageEnglish
dc.publisherBentham Science Publ Ltd
dc.sourceCurrent Neuropharmacology
dc.subjectNeurosciences
dc.subjectPharmacology
dc.subjectPharmacy
dc.titleCell death mechanisms in stroke and novel molecular and cellular treatment options
dc.typeReview
dspace.entity.typePublication
local.contributor.authorid0000-0002-4292-9761
local.contributor.authorid0000-0002-9472-1735
local.contributor.authorid0000-0002-0860-8964
local.contributor.kuauthorŞekerdağ, Emine
local.contributor.kuauthorSolaroğlu, İhsan
local.contributor.kuauthorÖzdemir, Yasemin Gürsoy

Files